Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wartenberg

Showing results (531-540 of 587) with videos related to

Pageof 59
Sort By:
Frontiers in Immunology|September 1, 2018
Aspf2 From <i>Aspergillus fumigatus</i> Recruits Human Immune Regulators for Immune Evasion and Cell DamagePrasad Dasari, Iordana A Shopova, Maria Stroe, et al.
Oncogene|June 9, 2016
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumorsF Röhrig, S Vorlová, H Hoffmann, et al.
Journal of Cancer Research and Clinical Oncology|August 13, 2022
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinomaAnn-Kristin Struckmeier, Anne Radermacher, Michael Fehrenz, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
The Lancet. Neurology|June 16, 2016
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialThorsten Steiner, Sven Poli, Martin Griebe, et al.
Oncogene|August 2, 2024
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancerHelene Hoffmann, Martin Wartenberg, Sandra Vorlova, et al.
Neurocritical Care|October 15, 2010
Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhageRichard E Temes, Elena Tessitore, J Michael Schmidt, et al.
Journal of Gastroenterology|February 1, 2026
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinomaSteve Robatel, Hanne Hillen, Ivanina Mutisheva, et al.
Neoplasia (New York, N.Y.)|April 20, 2021
SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targetsSandra N Freiberger, Muriel Brada, Christine Fritz, et al.
Journal of Neurosurgery|April 7, 2010
Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical articleFred Rincon, Errol Gordon, Robert M Starke, et al.
Pageof 59

Showing results (531-540 of 587) with videos related to

Sort By:
Pageof 59
Frontiers in Immunology|September 1, 2018
Aspf2 From <i>Aspergillus fumigatus</i> Recruits Human Immune Regulators for Immune Evasion and Cell DamagePrasad Dasari, Iordana A Shopova, Maria Stroe, et al.
Oncogene|June 9, 2016
VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumorsF Röhrig, S Vorlová, H Hoffmann, et al.
Journal of Cancer Research and Clinical Oncology|August 13, 2022
IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinomaAnn-Kristin Struckmeier, Anne Radermacher, Michael Fehrenz, et al.
Science Translational Medicine|November 5, 2025
A spatial atlas of human gastrointestinal acute GVHD reveals epithelial and immune dynamics underlying disease pathophysiologyNofar Azulay, Idan Milo, Yuval Bussi, et al.
The Lancet. Neurology|June 16, 2016
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trialThorsten Steiner, Sven Poli, Martin Griebe, et al.
Oncogene|August 2, 2024
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancerHelene Hoffmann, Martin Wartenberg, Sandra Vorlova, et al.
Neurocritical Care|October 15, 2010
Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhageRichard E Temes, Elena Tessitore, J Michael Schmidt, et al.
Journal of Gastroenterology|February 1, 2026
Agonistic GITR treatment enhances antitumor immune responses and suppresses tumor progression in pancreatic ductal adenocarcinomaSteve Robatel, Hanne Hillen, Ivanina Mutisheva, et al.
Neoplasia (New York, N.Y.)|April 20, 2021
SalvGlandDx - a comprehensive salivary gland neoplasm specific next generation sequencing panel to facilitate diagnosis and identify therapeutic targetsSandra N Freiberger, Muriel Brada, Christine Fritz, et al.
Journal of Neurosurgery|April 7, 2010
Predictors of long-term shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage. Clinical articleFred Rincon, Errol Gordon, Robert M Starke, et al.
Pageof 59